Pharvaris | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Venrock Healthcare Capital Partners III, L.P.(6.5%),VHCP Co-Investment Holdings III, LLC(6.5%), etc.
Pharvaris | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Viking Global Investors LP(7.0%),Viking Global Opportunities Parent GP LLC(7.0%), etc.
Pharvaris | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Foresite Capital Fund IV, L.P. (“FCF IV”)(7.8%),Foresite Capital Management IV, LLC (“FCM IV”)(7.8%), etc.
Pharvaris | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-General Atlantic, L.P.(14.1%),General Atlantic PH B.V.(14.1%), etc.
Pharvaris | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(9.989%),Abigail P. Johnson(9.989%)
Pharvaris | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-LSP V Coöperatieve U.A.(6.8%),LSP V Management B.V.(6.8%)
Pharvaris | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Corey Goodman(8.4%),Robert Adelman(8.4%), etc.
Pharvaris | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Bain Capital Life Sciences Fund, L.P.(3.8%),Bain Capital Life Sciences Opportunities III, LP(2.3%), etc.
Pharvaris | SC 13G: Statement of acquisition of beneficial ownership by individuals-Venrock Healthcare Capital Partners III, L.P.(6.1%),VHCP Co-Investment Holdings III, LLC(6.1%), etc.
Pharvaris | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Bain Capital Life Sciences Fund, L.P.(7.1%),Bain Capital Life Sciences Opportunities III, LP(4.1%), etc.
Pharvaris | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-General Atlantic, L.P.(10.8%),General Atlantic PH B.V.(10.8%), etc.
Pharvaris | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-venBio Global Strategic Fund III, L.P.(10.4%),venBio Global Strategic GP III, L.P.(10.4%), etc.
Pharvaris | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Viking Global Investors LP(9.7%),Viking Global Opportunities Parent GP LLC(9.7%), etc.
Pharvaris | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-James Tananbaum (“Tananbaum”)(9.7%),Foresite Capital Fund IV, L.P. (“FCF IV”)(9.6%), etc.
Pharvaris | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(9.999%),Abigail P. Johnson(9.999%)
Pharvaris | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-venBio Global Strategic Fund III, L.P.(6.9%),venBio Global Strategic GP III, L.P.(6.9%), etc.
Pharvaris | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Viking Global Investors LP(7.4%),Viking Global Opportunities Parent GP LLC(7.4%), etc.
Pharvaris | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-James Tananbaum (“Tananbaum”)(9.9%),Foresite Capital Fund IV, L.P. (“FCF IV”)(9.8%), etc.
Pharvaris | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions
Pharvaris | SC 13G: Statement of acquisition of beneficial ownership by individuals-LSP V Coöperatieve U.A.(10.9%),LSP V Management B.V.(10.9%)
No Data